KRT5 and breast cancer: Haughian et al.47 showed that over 50% of primary ER(+)PR(+) breast cancers contain an ER(-)PR(-)CK5(+) “lumino-basal” subpopulation, which is driven by Notch signaling and shows phenotype and GEP matching those of TNBC.